Moderna stock rallied on Friday. What about Pfizer?

 Dow Jones futures moved insignificantly versus fair value on Friday morning. The S&P 500 futures and Nasdaq futures also changed slightly while traders awaited a stimulus deal.

The stock market rallied on Thursday, hitting fresh highs with a stimulus deal seemingly close. During the session, Tesla (TSLA) skyrocketed to a record high.

Meanwhile, the Moderna Covid-19 vaccine and FedEx earnings gained attention later on Thursday. It seems Tesla stock will also be in focus on Friday as index funds will probably load up on shares before the stock joins the S&P 500 index before Monday’s open.

An FDA advisory panel gave the Moderna (MRNA) Covid-19 vaccine effusive recommendation for emergency use. Investors expect the FDA to do so within the next day or so. An FDA panel already backed the vaccine from Pfizer (PFE) and BioNTech (BNTX) on Dec. 10, with FDA approval coming Dec. 11. As a result, vaccinations began on Monday. Moderna stock climbed higher on Friday morning after declining overnight.

FedEx earnings easily overcome expectations amid the online shopping boom, but thus far the shipping giant didn’t give guidance. On Friday, FedEx stock tumbled down by 3% from near a buy point. UPS (UPS) also plummeted down in extended trade after closing in a buy range.

How did Dow Jones futures fare?

Dow Jones futures traded almost flat versus fair value. The S&P 500 futures increased slightly, but Nasdaq 100 futures lowered. On Thursday, the Dow Jones gained 0.5%, and the S&P 500 index surged forward by 0.6%. The Nasdaq composite jumped by 0.8% as well.

Among the several breakouts, Lululemon stock skyrocketed by 6.3% to 386.07. DraftKings stock also soared by 2.6% to 55.20.

Moderna stock plummeted down 2.7% after the FDA panel’s vote. However, shares had jumped by 5.1% on Thursday. At the same time, Pfizer stock gained 0.6% on Thursday, while BioNTech stock surged forward by 0.5%.